Federated Hermes Inc. Increases Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Federated Hermes Inc. raised its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MDFree Report) by 5.0% in the 4th quarter, Holdings Channel reports. The institutional investor owned 283,793 shares of the company’s stock after purchasing an additional 13,497 shares during the quarter. Federated Hermes Inc.’s holdings in Pediatrix Medical Group were worth $2,639,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Equita Financial Network Inc. purchased a new position in shares of Pediatrix Medical Group during the third quarter valued at approximately $128,000. AXQ Capital LP bought a new stake in shares of Pediatrix Medical Group during the third quarter valued at approximately $135,000. TD Asset Management Inc bought a new stake in shares of Pediatrix Medical Group during the third quarter valued at approximately $167,000. Corton Capital Inc. raised its stake in shares of Pediatrix Medical Group by 46.6% during the third quarter. Corton Capital Inc. now owns 15,180 shares of the company’s stock valued at $193,000 after acquiring an additional 4,828 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Pediatrix Medical Group by 9.7% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,340 shares of the company’s stock valued at $208,000 after acquiring an additional 1,443 shares in the last quarter. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on MD shares. Truist Financial decreased their price target on shares of Pediatrix Medical Group from $10.50 to $10.00 and set a “hold” rating for the company in a research note on Wednesday, February 21st. Jefferies Financial Group decreased their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “hold” rating for the company in a research note on Wednesday, March 6th. TheStreet downgraded shares of Pediatrix Medical Group from a “c” rating to a “d” rating in a research note on Friday, February 23rd. Finally, Mizuho decreased their price target on shares of Pediatrix Medical Group from $10.00 to $9.00 and set a “neutral” rating for the company in a research note on Wednesday, February 21st. Five research analysts have rated the stock with a hold rating, According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $10.30.

Check Out Our Latest Analysis on Pediatrix Medical Group

Pediatrix Medical Group Stock Performance

Shares of NYSE:MD opened at $9.04 on Friday. The company has a market capitalization of $759.63 million, a price-to-earnings ratio of -12.38, a price-to-earnings-growth ratio of 2.40 and a beta of 1.58. Pediatrix Medical Group, Inc. has a 52 week low of $7.70 and a 52 week high of $15.06. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.73. The firm has a 50 day moving average of $9.20 and a 200 day moving average of $9.61.

Pediatrix Medical Group (NYSE:MDGet Free Report) last issued its quarterly earnings data on Tuesday, February 20th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.30 by $0.02. The company had revenue of $496.44 million during the quarter, compared to the consensus estimate of $524.30 million. Pediatrix Medical Group had a negative net margin of 3.03% and a positive return on equity of 10.35%. Pediatrix Medical Group’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 earnings per share. On average, sell-side analysts predict that Pediatrix Medical Group, Inc. will post 1.12 earnings per share for the current fiscal year.

Pediatrix Medical Group Company Profile

(Free Report)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Read More

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MDFree Report).

Institutional Ownership by Quarter for Pediatrix Medical Group (NYSE:MD)

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.